Lesion-Related Carotid Angioplasty and Stenting with Closed-Cell Design without Embolic Protection Devices in High-Risk Elderly Patients—Can This Concept Work Out? A Single Center Experience Focusing on Stent Design

Silke Hopf-Jensen; Leonardo Marques; Michael Preiß; Stefan Müller-Hülsbeck

doi:10.1055/s-0034-1390084

International Journal of Angiology, Table of Contents

Int J Angiol 2014; 23(04): 263-270
DOI: 10.1055/s-0034-1390084

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Lesion-Related Carotid Angioplasty and Stenting with Closed-Cell Design without Embolic Protection Devices in High-Risk Elderly Patients—Can This Concept Work Out? A Single Center Experience Focusing on Stent Design

Silke Hopf-Jensen

¹Department of Diagnostic and Interventional Radiology and Neuroradiology, Diakonissenhospital Flensburg, Flensburg, Germany

,

Leonardo Marques

¹Department of Diagnostic and Interventional Radiology and Neuroradiology, Diakonissenhospital Flensburg, Flensburg, Germany

,

Michael Preiß

¹Department of Diagnostic and Interventional Radiology and Neuroradiology, Diakonissenhospital Flensburg, Flensburg, Germany

,

Stefan Müller-Hülsbeck

¹Department of Diagnostic and Interventional Radiology and Neuroradiology, Diakonissenhospital Flensburg, Flensburg, Germany

› Author Affiliations

Abstract

To compare the performance differences of three carotid artery stents in high-risk elderly patients without embolic protection devices (EPDs) on the basis of stent design, procedure-related complications, conveniences in handling, in-stent restenosis, 30-day outcome, and long-term follow-up. A total of 101 symptomatic internal carotid stenoses of 94 patients were prospectively treated with stent-protected angioplasty to 94 patients. Three closed-cell stents, one of those being hybrid cell design, were chosen depending on vascular anatomy: curved vessel, lesion length > 1 cm: 64 Carotid Wallstent (Boston Scientific, Natick, MA); curved vessel, lesion length < 1 cm: 21 Cristallo Ideale (Invatec, Roncadelle, Italy); straight vessel, lesion length > 1 cm: 16 Xact (Vascular Abbott, Santa Clara, CA). Comparisons of demographics, procedures, and outcomes were performed. The mean age of patients was 73.1 years (standard deviation [SD], ± 7.9; range, 58–87 years), 71% of the patients were older than 70 years and 20% were octogenarians. Male/female ratio was 3.1:1. About 13.9% (14/101) had contralateral internal carotid artery occlusion. Overall peri-interventional complication rate was 2.9% and 30-day mortality rate was 1%. During the long-term follow-up (34 months, range 1–59) no ipsilateral stroke was documented. Ten deaths (three after MI) were recognized. Two in-stent restenosis were detected (> 70% North American Symptomatic Carotid Endarterectomy Trial) during follow-up, one patient was detected with previous carotid endarterectomy. Especially, if individual anatomical variance is considered, lesion-related stent-protected carotid angioplasty with lesion-adapted closed-cell design is an effective, reliable, safe, and comprehensible treatment option in symptomatic patients. Even without EPDs, the rate of complications is low, when compared with symptomatic carotid artery stenosis described in the literature. In-stent restenosis seems to play no significant role in follow-up.

Keywords

carotid stent - carotid stenosis - closed-cell design - lesion related - symptomatic - carotid endarterectomy - CAS

Full Text

References

References
1 Dente K. Experts divided over carotid stenting for stroke prevention. Lancet Neurol 2006; 5 (1) 24
2 Mansour OY, Weber J, Niesen W, Schumacher M, Berlis A ; Safety and Efficacy Concerns-Single Center Experience. Carotid angioplasty and stenting without protection devices: safety and efficacy concerns—single center experience. Clin Neuroradiol 2011; 21 (2) 65-73
3 Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML, Sicard GA ; Outcomes Committee for the Society for Vascular Surgery. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg 2009; 49 (1) 71-79
4 Müller-Hülsbeck S, Preuss H, Elhöft H. CAS: which stent for which lesion. J Cardiovasc Surg (Torino) 2009; 50 (6) 767-772
5 Tietke MW, Kerby T, Alfke K , et al. Complication rate in unprotected carotid artery stenting with closed-cell stents. Neuroradiology 2010; 52 (7) 611-618
6 Müller-Hülsbeck S, Schäfer PJ, Charalambous N, Schaffner SR, Heller M, Jahnke T. Comparison of carotid stents: an in-vitro experiment focusing on stent design. J Endovasc Ther 2009; 16 (2) 168-177
7 Maleux G, Nevelsteen A. Carotid artery stenting: which stent for which lesion?. Acta Chir Belg 2002; 102 (6) 430-434
8 Moore WS, Barnett HJ, Beebe HG , et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 1995; 91 (2) 566-579
9 Cremonesi A, Gieowarsingh S, Spagnolo B , et al. Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry). EuroIntervention 2009; 5 (5) 589-598
10 Gross-Fengels W, Dörfler A, Berkefeld J, Huppert P. Diagnostik und Behandlung von Carotisstenosen: Die neue S3-Leitlinie aus radiologischer Sicht. Fortschr Röntgenstr 2013; 185 (2) 113-115
11 Kastrup A, Gröschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003; 34 (3) 813-819
12 Ringleb PA, Allenberg J, Brückmann H , et al; SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368 (9543) 1239-1247
13 Tietke M, Jansen O. Cerebral protection vs no cerebral protection: timing of stroke with CAS. J Cardiovasc Surg (Torino) 2009; 50 (6) 751-760
14 Biasi GM, Froio A, Diethrich EB , et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004; 110 (6) 756-762
15 Whitlow PL, Lylyk P, Londero H , et al. Carotid artery stenting protected with an emboli containment system. Stroke 2002; 33 (5) 1308-1314
16 Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003; 34 (8) 1936-1941
17 Müller-Hülsbeck S. Cerebral protection devices for treatment of carotid stenoses: Where do we stand today? [in German]. Rofo 2002; 174 (8) 945-954
18 Ohki T, Veith FJ. Critical analysis of distal protection devices. Semin Vasc Surg 2003; 16 (4) 317-325
19 Reimers B, Corvaja N, Moshiri S , et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001; 104 (1) 12-15
20 Cardaioli P, Giordan M, Panfili M, Chioin R. Complication with an embolic protection device during carotid angioplasty. Catheter Cardiovasc Interv 2004; 62 (2) 234-236
21 Giri J, Yeh RW, Kennedy KF , et al. Unprotected carotid artery stenting in modern practice. Catheter Cardiovasc Interv 2014; 83 (4) 595-602
22 Wu YM, Wong HF, Chen YL, Wong MC, Toh CH. Carotid stenting of asymptomatic and symptomatic carotid artery stenoses with and without the use of a distal embolic protection device. Acta Cardiol 2011; 66 (4) 453-458
23 Jansen O, Fiehler J, Hartmann M, Brückmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 2009; 40 (3) 841-846
24 Sayeed S, Stanziale SF, Wholey MH, Makaroun MS. Angiographic lesion characteristics can predict adverse outcomes after carotid artery stenting. J Vasc Surg 2008; 47 (1) 81-87
25 Hobson II RW, Howard VJ, Roubin GS , et al; CREST Investigators. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004; 40 (6) 1106-1111
26 Stanziale SF, Marone LK, Boules TN , et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg 2006; 43 (2) 297-304
27 Bonati LH, Dobson J, Algra A , et al; Carotid Stenting Trialists' Collaboration. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010; 376 (9746) 1062-1073